Intrinsic Value

Satsuma Pharmaceuticals, Inc. (STSA)

$6.37

+0.22 (+3.58%)

Enterprise Value -
Net Debt -14.76
Equity Value -
Shares Outstanding 31.53
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt